GLUtEus Maximus Fascia Plasty Flap for Pilonidal Sinus (GLUE)
Primary Purpose
Pilonidal Sinus
Status
Recruiting
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
Primary Closure
Gluteus Maximus Fascia Plasty Flap
Sponsored by
About this trial
This is an interventional treatment trial for Pilonidal Sinus focused on measuring pilonidal sinus, plasty, gluteus muscle fascia, ano-coccygeal plasty
Eligibility Criteria
Inclusion Criteria:
- Written informed consent
- Chronic primary or recurrent pilonidal sinus at the remission stage.
- Presence or absence of secondary orifices.
- Planned surgical treatment with excision of pilonidal sinus.
- Location of secondary orifices less than 2 cm from the natal cleft.
- The distance between bilateral symmetrical secondary orifices less than 2 cm.
- American Society Anesthesiologists (ASA) score 1 to 3
Non-inclusion Criteria:
- Acute pilonidal sinus abscess.
- The secondary openings (orifice) position more than 2 cm from the midline.
- ASA 4-5.
- Predictable impossibility of following the protocol.
- Pregnancy
Exclusion criteria:
1 The patients lost for the further observation. 2. The patient's refusal to continue participate in the investigation.
Sites / Locations
- Clinic of Colorectal and Minimally Invasive Surgery - I.M. Sechenov First Moscow State Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Primary Closure
Gluteus Maximus Plasty Flap
Arm Description
After pilonidal sinus is excised, subcutaneous fat and skin are closed in midline with a running suture
After pilonidal sinus is excised, gluteus maximus fascia flaps will be mobilised, approximated in the midline and fixed with a running suture. Subcutaneous fat and skin are closed in midline with a running suture.
Outcomes
Primary Outcome Measures
Recurrence rate
The rate of disease recurrence (clinical picture of pilonidal sinus and/or appearance of new openings in the intergluteal cleft and/or chronic unhealing wound and/or residual cavity in the wound area as confirmed by the soft tissue ultrasound)
Secondary Outcome Measures
Operative time
The length of surgery in minutes
Bloodloss
The amount of blood lost during surgery
Postoperative pain intensity - early postoperative period
Pain intensity will be evaluated twice a day (in the morning and in the evening) with a patient-reported Visual Analog Scale (VAS) that ranges from 0 to 10 with 0 representing no pain and 10 representing intolerable pain. A total score will be recorded.
Postoperative pain intensity - late postoperative period
Pain intensity will be evaluated once a day with a patient-reported Visual Analog Scale (VAS) that ranges from 0 to 10 with 0 representing no pain and 10 representing intolerable pain. A total score will be recorded.
Surgical site infection rate
The rate of infectious inflammation of the wound as confirmed by the observing doctor
Inhospital stay
The duration of treatment after surgery untill discharge from the hospital (in days)
Wound hemorrhage rate
The rate of hemorrhage from wound edges
Wound seroma rate
The rate of seroma detection in the wound area as confirmed by soft tissues ultrasound
Wound healing rate
The proportion of patients having their wound completely healed
Wound healing speed
The time period between surgery and complete healing of the wound
Secondary surgery rate
The rate of surgical procedures after initial surgery performed for recurrent disease and/or wound complications
Patient satisfaction with cosmetic results
Patient-reported with a scale 0-10, where 0 corresponds to "completely unsatisfactory" and 10 corresponds to "completely satisfactory". A total score is registered.
Overall quality of life
Assessed with patient-reported questionnaire SF-36. A total score in each of 8 sections will be calculated and transformed into a 0-100 scale with a score of zero equivalent to maximum disability and a score of 100 equivalent to no disability
Full Information
NCT ID
NCT03914729
First Posted
April 11, 2019
Last Updated
April 11, 2019
Sponsor
Russian Society of Colorectal Surgeons
1. Study Identification
Unique Protocol Identification Number
NCT03914729
Brief Title
GLUtEus Maximus Fascia Plasty Flap for Pilonidal Sinus
Acronym
GLUE
Official Title
Multicenter Randomized Controlled Trial of Mobilized Gluteus Maximus Muscle Fascia Flap Versus Primary Closure in the Treatment of Primary and Recurrent Pilonidal Sinus Disease.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Recruiting
Study Start Date
April 20, 2017 (Actual)
Primary Completion Date
December 30, 2019 (Anticipated)
Study Completion Date
December 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Russian Society of Colorectal Surgeons
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Surgical treatment is still gold standard for pilonidal sinus disease. Several surgical techniques have been proposed to treat this disease in the last two decades. A new method - midline excision of pilonidal sinus and wound closure using gluteus maximus fascia plasty flap (GMFF) - was proposed recently as a new method of treatment that results in low reccurence rate and good cosmetic results.
The aim of this study is to compare a new method (GMFF) with a traditional method (midline excision and primary closure) in terms of recurrence rate, complications and patient satisfaction with results.
Detailed Description
Pilonidal sinus disease (PSD) is a rather rare benign condition (about 26 cases per 100,000 population) that affects primarily young adults. Because of purulent nature it is treated with surgery only.
Traditional surgical techniques encompass midline excision of the purulent cyst and either leaving the wound "lay open" for secondary closure or midline primary closure. The latter method has a major drawback of high recurrence rate and very long healing and patient disability periods. Therefore alternative techniques to close the wound after pilonidal sinus excision were proposed. In some a muscular-cutaneous flaps are created and the wound is closed in a Z- or Y- or other shape manner. The recurrence rate of these techniques is significantly lower than with a traditional midline closure, but healing time and final cosmetic results are far from ideal in patient view.
Recently a new method of wound closure was developed independently by a few groups that includes bilateral mobilisation of gluteus maximus muscles fascia and midline closure of the wound. Preliminary results demonstrated that this method leads to lower recurrence rate and better cosmetic results because the natal cleft is saved.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pilonidal Sinus
Keywords
pilonidal sinus, plasty, gluteus muscle fascia, ano-coccygeal plasty
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective, multi-centre, parallel-arm randomized controlled trial
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
84 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Primary Closure
Arm Type
Active Comparator
Arm Description
After pilonidal sinus is excised, subcutaneous fat and skin are closed in midline with a running suture
Arm Title
Gluteus Maximus Plasty Flap
Arm Type
Active Comparator
Arm Description
After pilonidal sinus is excised, gluteus maximus fascia flaps will be mobilised, approximated in the midline and fixed with a running suture. Subcutaneous fat and skin are closed in midline with a running suture.
Intervention Type
Procedure
Intervention Name(s)
Primary Closure
Intervention Description
A symmetrical elliptical incision of skin and subcutaneous fat around primary and secondary orifices is performed. The cyst is excised en bloc down to the sacral fascia and removed. The lateral edges of the wound are approximated and sutured in the midline: subcutaneous fat - with a running suture, skin - with a separate running suture.
Intervention Type
Procedure
Intervention Name(s)
Gluteus Maximus Fascia Plasty Flap
Intervention Description
A symmetrical elliptical incision of skin and subcutaneous fat around primary and secondary orifices is performed. The cyst is excised en bloc down to the sacral fascia and removed. The lateral edges of the gluteus maximus muscles fascia bilaterally are mobilised in the direction from the fixation point to the sacrum and for 3-4 cm in lateral direction. The fascia flaps edges are approximated and fixed in the midline with a running suture. The subcutaneous fat is closed with a running suture, skin is closed with a separate running suture.
Primary Outcome Measure Information:
Title
Recurrence rate
Description
The rate of disease recurrence (clinical picture of pilonidal sinus and/or appearance of new openings in the intergluteal cleft and/or chronic unhealing wound and/or residual cavity in the wound area as confirmed by the soft tissue ultrasound)
Time Frame
starting from 6 months after surgery and up to 5 years after surgery
Secondary Outcome Measure Information:
Title
Operative time
Description
The length of surgery in minutes
Time Frame
1 day
Title
Bloodloss
Description
The amount of blood lost during surgery
Time Frame
1 day
Title
Postoperative pain intensity - early postoperative period
Description
Pain intensity will be evaluated twice a day (in the morning and in the evening) with a patient-reported Visual Analog Scale (VAS) that ranges from 0 to 10 with 0 representing no pain and 10 representing intolerable pain. A total score will be recorded.
Time Frame
On 1st, 3rd, 5th and 7th postoperative day
Title
Postoperative pain intensity - late postoperative period
Description
Pain intensity will be evaluated once a day with a patient-reported Visual Analog Scale (VAS) that ranges from 0 to 10 with 0 representing no pain and 10 representing intolerable pain. A total score will be recorded.
Time Frame
On 10th, 14th, 21st, 30 day after surgery
Title
Surgical site infection rate
Description
The rate of infectious inflammation of the wound as confirmed by the observing doctor
Time Frame
3 month after surgery
Title
Inhospital stay
Description
The duration of treatment after surgery untill discharge from the hospital (in days)
Time Frame
30 days
Title
Wound hemorrhage rate
Description
The rate of hemorrhage from wound edges
Time Frame
Within 30 days from surgery
Title
Wound seroma rate
Description
The rate of seroma detection in the wound area as confirmed by soft tissues ultrasound
Time Frame
90 days after surgery
Title
Wound healing rate
Description
The proportion of patients having their wound completely healed
Time Frame
6 months after surgery
Title
Wound healing speed
Description
The time period between surgery and complete healing of the wound
Time Frame
5 years after surgery
Title
Secondary surgery rate
Description
The rate of surgical procedures after initial surgery performed for recurrent disease and/or wound complications
Time Frame
5 years
Title
Patient satisfaction with cosmetic results
Description
Patient-reported with a scale 0-10, where 0 corresponds to "completely unsatisfactory" and 10 corresponds to "completely satisfactory". A total score is registered.
Time Frame
6 months, 1 year, 3 years, 5 years after surgery
Title
Overall quality of life
Description
Assessed with patient-reported questionnaire SF-36. A total score in each of 8 sections will be calculated and transformed into a 0-100 scale with a score of zero equivalent to maximum disability and a score of 100 equivalent to no disability
Time Frame
1-7 days before surgery, 1 month, 3 months, 1 year, 3 years, 5 years after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Written informed consent
Chronic primary or recurrent pilonidal sinus at the remission stage.
Presence or absence of secondary orifices.
Planned surgical treatment with excision of pilonidal sinus.
Location of secondary orifices less than 2 cm from the natal cleft.
The distance between bilateral symmetrical secondary orifices less than 2 cm.
American Society Anesthesiologists (ASA) score 1 to 3
Non-inclusion Criteria:
Acute pilonidal sinus abscess.
The secondary openings (orifice) position more than 2 cm from the midline.
ASA 4-5.
Predictable impossibility of following the protocol.
Pregnancy
Exclusion criteria:
1 The patients lost for the further observation. 2. The patient's refusal to continue participate in the investigation.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Darya Shlyk, MD
Phone
+ 7-920-520-77-06
Email
shlyk@kkmx.ru
First Name & Middle Initial & Last Name or Official Title & Degree
Arcangelo Picciariello, MD
Phone
+393492185104
Email
picciariello@kkmx.ru
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Inna Tulina, PhD
Organizational Affiliation
I.M. Sechenov First Moscow State Medical University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Petr Tsarkov, Prof.
Organizational Affiliation
Russian Society of Colorectal Surgeons
Official's Role
Study Director
Facility Information:
Facility Name
Clinic of Colorectal and Minimally Invasive Surgery - I.M. Sechenov First Moscow State Medical University
City
Moscow
ZIP/Postal Code
119435
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Darya + 7-920-520-77-06 Shlyk, MD
Phone
+ 7-920-520-77-06
Email
shlyk@kkmx.ru
12. IPD Sharing Statement
Citations:
PubMed Identifier
12750948
Citation
Chintapatla S, Safarani N, Kumar S, Haboubi N. Sacrococcygeal pilonidal sinus: historical review, pathological insight and surgical options. Tech Coloproctol. 2003 Apr;7(1):3-8. doi: 10.1007/s101510300001.
Results Reference
result
PubMed Identifier
7745322
Citation
Sondenaa K, Andersen E, Nesvik I, Soreide JA. Patient characteristics and symptoms in chronic pilonidal sinus disease. Int J Colorectal Dis. 1995;10(1):39-42. doi: 10.1007/BF00337585.
Results Reference
result
PubMed Identifier
27311698
Citation
Iesalnieks I, Ommer A, Petersen S, Doll D, Herold A. German national guideline on the management of pilonidal disease. Langenbecks Arch Surg. 2016 Aug;401(5):599-609. doi: 10.1007/s00423-016-1463-7. Epub 2016 Jun 16.
Results Reference
result
PubMed Identifier
29699781
Citation
Milone M, Velotti N, Manigrasso M, Anoldo P, Milone F, De Palma GD. Long-term follow-up for pilonidal sinus surgery: A review of literature with metanalysis. Surgeon. 2018 Oct;16(5):315-320. doi: 10.1016/j.surge.2018.03.009. Epub 2018 Apr 24.
Results Reference
result
PubMed Identifier
30640830
Citation
Johnson EK, Vogel JD, Cowan ML, Feingold DL, Steele SR; Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons' Clinical Practice Guidelines for the Management of Pilonidal Disease. Dis Colon Rectum. 2019 Feb;62(2):146-157. doi: 10.1097/DCR.0000000000001237. No abstract available.
Results Reference
result
Learn more about this trial
GLUtEus Maximus Fascia Plasty Flap for Pilonidal Sinus
We'll reach out to this number within 24 hrs